Injectable RNA-based therapies that prevent translation of LPA messenger RNA may block the production of ApoA used in Lp(a) synthesis. Ballantyne first highlighted the small interfering RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback